Diagnosis and Management of Hydroa Vacciniforme
DOI:
https://doi.org/10.55175/cdk.v51i5.902Keywords:
hydroa vacciniforme, diagnosis, photodermatoses, managementAbstract
Hydroa vacciniforme (HV) is a rare photodermatoses with the most frequent onset in childhood. The exact pathogenesis of HV is still not known. This disease is a spectrum with almost similar clinical symptoms, but with a very different prognosis. Classic HV has the best prognosis, but affects the quality of life due to scar formation, while hydroa vacciniforme-like lymphoma (HVLL) is the variant with the worst prognosis. HV needs to be considered as a differential diagnosis, especially in childhood-onset photodermatoses. Classical HV must be distinguishes from hydroa vacciniforme-like lymphoproliferative disorders (HVLPD) because it is related to prognosis. There is still no consensus or guidelines on diagnosis and management for HV.
Downloads
References
Vandergriff T. Hydroa vacciniforme. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al, editors. Fitzpatrick’s dermatology. 9th Ed. McGraw-Hill Education; 2019. p. 1634–7.
Chen CC, Chang KC, Medeiros LJ, Lee JYY. Hydroa vacciniforme and hydroa vacciniforme-like lymphoproliferative disorder: A spectrum of disease phenotypes associated with ultraviolet irradiation and chronic epstein–barr virus infection. Int J Mol Sci. 2020;21:9314.
Quintanilla-Martinez L, Fend F. Deciphering hydroa vacciniforme. Blood 2019;133:2735–7.
Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, et al. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. J Dermatol. 2021;48(9):1315–26.
Departemen Dermatologi dan Venereologi Rumah Sakit Cipto Mangunkusumo (DV RSCM). Data kasus rawat inap dan rawat jalan Departemen DV RSCM tahun 2013-2021. Jakarta; 2022
Huggins RH, Leithauser LA, Eide MJ, Hexsel CL, Jacobsen G, Lim HW. Quality of life assessment and disease experience of patient members of a web-based hydroa vacciniforme support group. Photodermatol Photoimmunol Photomed. 2009;25(4):209-15
Nahhas AF, Oberlin DM, Braunberger TL, Lim HW. Recent developments in the diagnosis and management of photosensitive disorders. Am J Clin Dermatol. 2018;19:707–31.
Verneuil L, Gouarin S, Comoz F, Agbalika F, Creveuil C, Varna M, et al. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: An assessment of seven adult patients with long-term follow-up. Br J Dermatol. 2010;163(1):174–82.
Hirai Y, Yamamoto T, Kimura H, Ito Y, Tsuji K, Miyake T, et al. Hydroa vacciniforme is associated with increased numbers of epstein-barr virus-infected γδT cells. J Invest Dermatol. 2012;132:1401–8.
Miyake T, Iwatsuki K, Hirai Y, Yamamoto T, Hamada T, Fujii K, et al. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites. J Med Virol. 2020;92:3689–96.
Hamel R, Mohammad TF, Chahine A, Joselow A, Vick G, Radosta S, et al. Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1080 patients over a 10-year period. Photodermatol Photoimmunol Photomed. 2020;36(3):233–40.
Rutter KJ, Ashraf I, Cordingley L, Rhodes LE. Quality of life and psychological impact in the photodermatoses: A systematic review. Br J Dermatol. 2020;182:1092–102.
Cohen JI, Manoli I, Dowdell K, Krogmann TA, Tamura D, Radecki P, et al. Hydroa vacciniforme-like lymphoproliferative disorder: An EBV disease with a low risk of systemic illness in whites. Blood 2019;133:2753-64.
Gru AA, Jaffe ES. Cutaneous EBV-related lymphoproliferative disorders. Semin Diagn Pathol. 2017;34:60–75.
Jiang AJ, Lim HW. Phototherapy in the evaluation and management of photodermatoses. Dermatol Clin. 2020;38:71–7
Young AR. Principles of phototherapy. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. 9th Ed. West Sussex: Wiley Blackwell; 2016. p. 21.7
Ren F, Zhu J, Perry DM, Pruitt L, Elston DM. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective cohort study of seven pediatric cases. Int J Dermatol. 2020;59:e290–2.
Xie Y, Wang T, Wang L. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients. J Dermatol Sci. 2020;99:128–34.
Hue SSS, Oon ML, Wang S, Tan SY, Ng SB. Epstein–Barr virus-associated T-and NK-cell lymphoproliferative diseases: An update and diagnostic approach. Pathology 2020;52:111–27.
Liu Y, Ma C, Wang G, Wang L. Hydroa vacciniforme–like lymphoproliferative disorder: Clinicopathologic study of 41 cases. J Am Acad Dermatol. 2019;81:534–40.
Chen CC, Chang KC, Jeffrey Medeiros L, Yu-Yun Lee J. Hydroa vacciniforme and hydroa vacciniforme-like t-cell lymphoma: An uncommon event for transformation. J Cutan Pathol. 2016;43(12):1102-11.
Wen PF, Zhang M, Wang TT, Liu HJ, Zhang WY, Liu WP, et al. Comparative study of the clinical pathology, immunophenotype, epstein-barr virus infection status, and gene rearrangements in adult and child patients with hydroa vacciniforme-like lymphoproliferative disorder. Am J Dermatopathol. 2019;41(1):7-15.
Adler BL, DeLeo VA. Actinic prurigo and hydroa vacciniforme. Curr Derm Rep. 2019;8:63–72.
Ruan Y, Shen X, Shi R, Zhao X, Zheng J. Hydroa vacciniforme-like lymphoproliferative disorder treated with intravenous immunoglobulin: Longterm remission without haematopoietic stem cell transplantation or chemotherapy. Acta Derm Venereol. 2020;100:1–2.
Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, et al. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: An analysis of prognostic implications and treatment based on 19 cases. Diagn Pathol. 2019;14(1):82
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Reisa Reshinta, Githa Rahmayunita, Rahadi Rihatmadja, Rinadewi Astriningrum
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
